Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001831:Body Temperature / Q000187:drug effects; D002250:Carbon Radioisotopes; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology*; D002852:Chromatography, Ion Exchange; D003837:Deoxy Sugars / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D005956:Glucose-6-Phosphate Isomerase / Q000037:antagonists & inhibitors; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D005958:Glucosephosphates / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects; D006168:Guinea Pigs; D006593:Hexokinase / Q000037:antagonists & inhibitors; D008297:Male; D051379:Mice; D010725:Phosphocreatine / Q000378:metabolism; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors; D010733:Phosphoglucomutase / Q000037:antagonists & inhibitors; D010734:Phosphogluconate Dehydrogenase / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D001786:Blood Glucose; D002250:Carbon Radioisotopes; D003837:Deoxy Sugars; D005958:Glucosephosphates; D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D011433:Propranolol; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D006593:Hexokinase; D010732:Phosphofructokinase-1; D005956:Glucose-6-Phosphate Isomerase; D010733:Phosphoglucomutase; D005947:Glucose